Skip to content
Screener

TG Therapeutics TGTX Other Selling General And Administrative Expense

Other Selling General And Administrative Expense at other companies

TG Therapeutics logo
TG TherapeuticsTGTX
$62.33M+43.1%
Mayville Engineering logo
Mayville EngineeringMEC
$9.32M-9.4%
Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
$128.08M+13.8%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$198K+200%
Security National Financial Corporation logo
Security National Financial CorporationSNFCA
$1.87M+14.1%
Pool Corporation logo
Pool CorporationPOOL
$103.65M+262%

Other financials

Income statement

See full
Revenue$240.3M+70.3%
Gross profit$199.1M+62.9%
Operating income$21.7M-37.8%
Net income$7.8M-72.4%
EPS (diluted)$0.05-70.6%

Balance sheet

See full
Cash & equivalents$482.6M+274%
Total debt$754.4M+197%
Total equity$604.1M+119%
Total assets$1.6B+133%

Cash flow

See full
Operating cash flow$39.3M
CapEx$293.0K+598%
Free cash flow$39.0M

Valuation

See full
Market cap$7.64B+73.6%
Enterprise value$7.91B+74.9%
P/E17.3×-55.5×
P/S9.6×-0.1×

Profitability

See full
Gross margin82.4%-4.6pp
Operating margin17.1%-1.9pp
Net margin55.2%+41.9pp
FCF margin-6,328.4%+4,773pp

Returns & leverage

See full
Return on equity100.3%+73.6pp
Debt / equity1.2×+0.3×
Current ratio4.3×+0.4×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherSellingGeneralAndAdministrativeExpense.

The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:01 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-025955

FAQ

What is TG Therapeutics's other selling general and administrative expense?
TG Therapeutics (TGTX) reported other selling general and administrative expense of $62.33M in Q2 2026.
How has TG Therapeutics's other selling general and administrative expense changed year-over-year?
TG Therapeutics's other selling general and administrative expense increased by 43.1% year-over-year, from $43.54M to $62.33M.
What is the long-term trend for TG Therapeutics's other selling general and administrative expense?
Over 4 years (2021 to 2025), TG Therapeutics's other selling general and administrative expense has grown at a 19.3% compound annual growth rate (CAGR), from $90.86M to $183.98M.
What does other selling general and administrative expense mean?
Other Selling General And Administrative Expense as reported by TG Therapeutics, Inc..

Ask your AI about TG Therapeutics's other selling general and administrative expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude